Compounds > 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine
Page last updated: 2024-09-02

1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine and n-methylaspartate

1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine has been researched along with n-methylaspartate in 1 studies

Compound Research Comparison

Studies
(1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine)		Trials
(1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine)		Recent Studies (post-2010)
(1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine)		Studies
(n-methylaspartate)		Trials
(n-methylaspartate)		Recent Studies (post-2010) (n-methylaspartate)
90210,408591,902

Protein Interaction Comparison

ProteinTaxonomy1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine (IC50)n-methylaspartate (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)5.175
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)5.175

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1

Other Studies

1 other study(ies) available for 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine and n-methylaspartate

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007